pillbase.ru

Aerivio Spiromax

Active substance: salmeterol xinafoate, fluticasone propionate

salmeterol xinafoate, fluticasone propionate

Centralised EU authorisationWithdrawn

Marketing holder: Teva B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Products containing salmeterol xinafoate in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 61
  • ADVAIR DISKUS
    POWDER · SALMETEROL XINAFOATE 50 ug/1, FLUTICASONE PROPIONATE 100 ug/1
    50090-0730
    A-S Medication Solutions
  • ADVAIR DISKUS
    POWDER · SALMETEROL XINAFOATE 50 ug/1, FLUTICASONE PROPIONATE 250 ug/1
    50090-4502
    A-S Medication Solutions
  • ADVAIR DISKUS
    POWDER · SALMETEROL XINAFOATE 50 ug/1, FLUTICASONE PROPIONATE 500 ug/1
    50090-4505
    A-S Medication Solutions
  • ADVAIR DISKUS
    POWDER · SALMETEROL XINAFOATE 50 ug/1, FLUTICASONE PROPIONATE 500 ug/1
    50090-0732
    A-S Medication Solutions
  • ADVAIR DISKUS
    POWDER · SALMETEROL XINAFOATE 50 ug/1, FLUTICASONE PROPIONATE 250 ug/1
    50090-0731
    A-S Medication Solutions
All products in this country (61)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-1b7c-7066-8cfa-96a00dba453f;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002752
Registration status
Withdrawn
ATC code
R03AK06
Sources
  • product · EMA · EMEA/H/C/002752 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002752 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002752 · Verified 2026-10-09
  • ingredients.1 · EMA · EMEA/H/C/002752 · Verified 2026-10-09